Skip to main content

Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Allogeneic haemopoietic stem cell transplant (alloHSCT) patients are at increased risk of osteoporosis. Zoledronic acid (ZA) is a potent i.v. bisphosphonate; however, there are few data on ZA use after alloHSCT. The aim of this study is to examine the effect of a single 4 mg ZA infusion in alloHSCT patients with either osteoporosis (T‐score < −2.5) or rapid bone loss post‐alloHSCT. An uncontrolled, prospective study of 12 consecutive patients receiving ZA, predominantly within the first year post‐HSCT. Bone mineral density (BMD) was measured by dual‐energy X‐ray absorptiometry at the spine and proximal femur pretransplant, pre‐ZA and post‐ZA. The median annualized percentage change in total hip BMD between the pretransplant scan and the scan immediately before ZA was −13% (range, −51 to +3.6%). After ZA treatment, the total hip BMD increased by a median of +3.3% (range, −20.4 to +14.8%) in 75% of patients. The median annualized percentage change in femoral neck BMD between the pretransplant scan and the scan immediately before ZA was −13.2% (range, −40 to +1.0%). Post‐ZA, femoral neck BMD increased by a median of +1.4% (range, −22.2 to +33.6%). Only one patient continued to lose bone from the femoral neck post‐ZA infusion. The median annualized percentage change in spinal BMD pretransplant was −12.5% (range, −38 to +6.9%). Post‐ZA, spinal BMD decreased by a median of −2.8% (range, −27.6 to +24.4%). Four patients continued to lose bone from the spine post‐ZA. ZA reduces bone loss in most patients after alloHSCT. Our data require confirmation in a larger prospective, randomized study.

Keywords: allogeneic stem cell transplant; bone loss; osteoporosis; zoledronic acid

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1445-5994.2006.01154.x

Affiliations: Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia

Publication date: 2006-09-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more